BNED vs STRT

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no Altman Z-Score available, leaving bankruptcy risk unconfirmed but concerning given high leverage. Despite a low current P/E of 12.89 compared to sector average of 53.76, the negative forward P/E (-0.25) and collapsing earnings growth (-62% YoY) signal deteriorating profitability. The stock trades above the Graham Number of $11.53 but well above the intrinsic value of $4.97, suggesting overvaluation on a conservative basis. Persistent negative earnings surprises, declining ROE, and weak insider sentiment (40/100) further undermine confidence in a near-term turnaround.

STRT presents a compelling value opportunity, trading at $80.70, which is below its Graham Number ($93.14) and significantly below its intrinsic value ($194.7). The company's financial health is stable with a Piotroski F-Score of 4/9, underpinned by an elite balance sheet featuring a near-zero Debt/Equity ratio (0.01) and strong liquidity (Current Ratio 2.61). While technical trends and insider sentiment are currently bearish, the explosive YoY earnings growth (275%) and a P/E ratio (12.23) far below the sector average (34.48) suggest substantial upside potential.